Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Pathogenic variants of homologous recombination repair-related genes in advanced pancreatic cancer and oxaliplatin-based chemotherapy: Prospective multicenter observational study.
Authors
Tomohiro Kondo
Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan
Tomohiro Kondo , Daisuke Yamaguchi , Junichi Matsubara , Takashi Ura , Motoo Nomura , Taro Funakoshi , Akira Yokoyama , Keitaro Doi , Masashi Tamaoki , Tadayuki Kou , Toshinao Itani , Michio Yoshimura , Norimitsu Uza , Takahiro Yamada , Toshihiko Masui , Sachiko Minamiguchi , Hideki Ishikawa , Shigemi Matsumoto , Manabu Muto , Masashi Kanai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
UMIN000033655
DOI
10.1200/JCO.2022.40.4_suppl.555
Abstract #
555
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2022 ASCO Annual Meeting
A descriptive study on the treatment and outcomes of patients with platinum-sensitive, advanced, BRCA- or PALB2-related pancreatic cancer who have progressed on rucaparib.
First Author: Timothy J Brown
Poster
2022 ASCO Annual Meeting
DOLAF: An international multicenter phase II trial of durvalumab (MEDI4736) plus olaparib plus fulvestrant in patients with metastatic or locally advanced ER-positive, HER2-negative breast cancer selected using criteria that predict sensitivity to olaparib.
First Author: Severine Guiu Lahaye
Poster
2022 ASCO Gastrointestinal Cancers Symposium
The impact of germline and somatic mutations in the homologous recombination repair pathway in pancreatic cancer patients who undergo perioperative chemotherapy.
First Author: Gudbjorg Jonsdottir